Research Topics
Species | Alberto LuiniSummaryAffiliation: European Institute of Oncology Country: Italy Publications
| Collaborators
|
Detail Information
Publications
The surgical margin status after breast-conserving surgery: discussion of an open issueAlberto Luini
Senology Division, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 113:397-402. 2009..Radiation therapy could be a good option in the management of these cases, but further evidence is needed to establish the real impact of clear surgical margins on local control of disease and, furthermore, on survival...
The evolution of the conservative approach to breast cancerAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Breast 16:120-9. 2007..For this reason in our Institute we are now evaluating the feasibility of a reduction of the radiation field and the sensibility and sensitivity of new diagnostic approaches for axillary staging...
Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinomaAlberto Luini
Senology Division, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Arch Surg 137:1157-60. 2002..This method represents an interesting development in breast-conserving surgery...
The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the resultsAlberto Luini
Division of Breast Surgery, University of Milan, Milan, Italy
Breast Cancer Res Treat 93:55-9. 2005..At the European Institute of Oncology we started our study on ELIOT in 1999; the first step has been a phase I-II trial to test feasibility and tolerance of ELIOT in patients candidate to breast conserving surgery...
The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of OncologyAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast Cancer Res Treat 89:159-63. 2005..A previous breast biopsy has been considered a relative contraindication to SLNB. We examined the accuracy of SLNB by following the axillary relapses after the procedure in patients who had undergone a breast biopsy before SLNB...
Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literatureAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 105:81-5. 2007..We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed...
Development of axillary surgery in breast cancerA Luini
Division of Breast Surgery, European Institute of Oncology, Via G Ripamonti 435, 20141 Milan, Italy
Ann Oncol 16:259-62. 2005..We discuss the evolution of axillary surgery in breast cancer...
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literatureAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 101:349-53. 2007..The purpose of the present study was to compare the clinical course, and prognosis, between this type of tumor and poorly differentiated ductal carcinoma...
Male breast cancer in a young patient treated with nipple-sparing mastectomy: case report and review of the literatureAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Tumori 93:118-20. 2007..We here describe a case of male breast carcinoma in a young patient (44 years of age), which is quite unusual in the pattern of breast carcinoma presentation...
Conservative treatment of breast cancer: its evolutionAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 94:195-8. 2005..From an oncological perspective, outcome was found to be equally effective, and this key observation provided us with significant impetus to investigate the effects of reducing the radiotherapy field...
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline featuresEmilia Montagna
Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 124:689-99. 2010..A substantial rate of relapse was observed for patients with large tumors and with clinical nodal involvement at baseline. Further improvement in adjuvant treatment might be warranted...
Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 casesUmberto Veronesi
Scientific Director European Institute of Oncology, Via G Ripamonti 435, I 20141 Milan, Italy
Eur J Cancer 45:1381-8. 2009..PREMISES: Sentinel node biopsy (SNB) in patients with breast carcinoma accurately predicts the axillary node status. However, in some 4-7% of patients with negative sentinel nodes, the remaining axillary nodes harbour cancer cells...
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyUmberto Veronesi
Scientific Direction, European Institute of Oncology, Milan, Italy
Lancet Oncol 7:983-90. 2006..Results of our previous trial showed that SLNB accurately screens the ALN for metastasis in breast cancers of diameter 2 mm or less. We aimed to update this trial with results from longer follow-up...
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivityGiuseppe Viale
Division of Pathology, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 116:317-28. 2009..EGFR immunoreactivity significantly correlates with worse prognosis in patients with triple-negative IDC, supporting further studies on the correlation between the degree of EGFR expression and outcome of triple negative breast cancer...
Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of OncologySimonetta Monti
Division of Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy
Ann Surg Oncol 14:2928-31. 2007..We report our experience using radio-guided occult lesion localization (ROLL) for locating and removing non-palpable breast lesions together with sentinel node biopsy (SNB) to assess axillary status. We call the technique SNOLL...
Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancerRosalba Torrisi
Research Unit of Medical Senology, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Breast 20:34-8. 2011..To explore the activity of pegylated liposomal doxorubicin (PLD) as neoadjuvant therapy of breast cancer...
Local therapy for breast cancer in malignant lymphoma survivorsMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast 20:S99-103. 2011..We performed a retrospective review to assess the potential of performing breast conservative surgery and intraoperative radiotherapy with electrons (ELIOT), in these patients...
Positive axillary sentinel lymph node: is axillary dissection always necessary?Viviana Galimberti
Division ofSenology, European Institute of Oncology, Milan, Italy
Breast 20:S96-8. 2011..Ancillary analyses of the IBCSG 23-01 and AMAROS trials, still in follow-up, may be able to do this...
Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancerGiovanni Paganelli
Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy
Clin Cancer Res 13:5646s-5651s. 2007..In a continuous effort to seek for anticancer treatments with minimal side effects, we aim at proving the feasibility of the Intraoperative Avidination for Radionuclide Therapy, a new procedure for partial breast irradiation...
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancerUmberto Veronesi
Division of Senology, European Institute of Oncology, Milan, Italy
N Engl J Med 349:546-53. 2003..Although numerous studies have shown that the status of the sentinel node is an accurate predictor of the status of the axillary nodes in breast cancer, the efficacy and safety of sentinel-node biopsy require validation...
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcomeOreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
J Surg Oncol 94:375-9. 2006..To evaluate the ipsilateral breast tumor reappearance (IBTR) rate after breast conservative surgery (BCS) following primary chemotherapy (PC) and to assess whether positive margins affects IBTR rate and overall survival (OS)...
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 casesUmberto Veronesi
Istituto Europeo di Oncologia, Division of Radiotherapy, Istituto Europeo di Oncologia, Milan, Italy
Ann Surg 242:101-6. 2005..The new mobile linear accelerators easily moved close to the operating table to allow the full-dose irradiation during surgery...
Sentinel lymph node biopsy is feasible even after total mastectomyMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
J Surg Oncol 95:175-9. 2007..Previous mastectomy is unanimously considered to represent an absolute technical contraindication to sentinel lymph node biopsy (SLNB)...
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?Viviana Galimberti
Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 131:819-25. 2012..Nevertheless, a subset of patients might be at high risk of developing overt axillary disease and efforts should be made to identify such patients by ancillary analyses of the results of ongoing or recently published clinical trials...
Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of OncologyViviana Galimberti
Department of Senology, European Institute of Oncology, Milan, Italy
Tumori 94:52-8. 2008..We performed a retrospective analysis of patients with 4 or more axillary nodes involved and sufficient follow-up to provide indications as to whether our current treatment is adequate...
Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasiaBernardo Bonanni
Divisions of Cancer Prevention and Genetics, European Institute of Oncology, Milan, University of Milan School of Medicine, Milan, Italy
Clin Cancer Res 15:7053-60. 2009..The influence of CYP2D6 genotype on tamoxifen effects was also determined...
Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancerSilvia Dellapasqua
Medical Senology Research Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast 20:319-23. 2011..To evaluate the role of pegylated liposomal doxorubicin with low-dose metronomic cyclophosphamide as primary systemic treatment in locally advanced breast cancer...
Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissectionUmberto Veronesi
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Eur J Cancer 41:231-7. 2005..The 5 year overall survival rate of the whole series was 98%. Patients with negative sentinel node biopsies not submitted to axillary dissection show during follow-up a rate of overt axillary metastases that is lower than that expected...
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatmentJean Yves Petit
Division of Plastic Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 96:47-51. 2006..In fact, although removal of the NAC greatly increases the patient's sensation of mutilation, and the risk of tumor involvement of the areola is reported as a very variable percentage, NAC excision still remains the standard treatment...
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxelRosalba Torrisi
Research Unit of Medical Senology, European Institute of Oncology, Via Ripamonti, 435 20141, Milan, Italy
Cancer Chemother Pharmacol 62:667-72. 2008..No specific treatment guidelines are available for triple-negative breast cancers, defined by a lack of expression of estrogen (ER), progesterone (PgR), and HER2 receptors...
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electronsUmberto Veronesi
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast Cancer Res Treat 124:141-51. 2010..4 and 89.7%. ELIOT appears a promising feature in early breast cancer treated with breast conserving surgery, reducing the exposure of normal tissues to radiations and shortening the radiation course from 6 weeks to one single session...
Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancerMario Ciocca
Department of Medical Physics, European Institute of Oncology, Milano, Italy
Radiother Oncol 78:213-6. 2006..In the present study, a further step was made, aiming at the improvement of the effectiveness of in vivo dosimetry, based on a real-time check of the dose...
Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsyMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141, Milan, Italy
Ann Surg Oncol 12:895-9. 2005..Although a previous SLNB is often considered a contraindication for a subsequent SLNB, few data support this concern...
Nonpalpable breast carcinomas: long-term evaluation of 1,258 casesUmberto Veronesi
IEO European Institute of Oncology, Milan, Italy
Oncologist 15:1248-52. 2010..At present in our institution some 20% of the cases are treated when nonpalpable. The aim of the present study is to analyze the characteristics and prognosis of such tumors treated in a single institution...
Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled studyUmberto Veronesi
European Institute of Oncology, Milan, Italy
Ann Surg 251:595-600. 2010..We present 10-year follow-up of our single-institute trial designed to compare outcomes in patients who received no axillary dissection if the sentinel node was negative, with patients who received complete axillary dissection...
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?Carlos A Garcia-Etienne
Breast Surgery Department, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 16:3380-7. 2009..The optimal local therapy for women with BRCA-associated breast carcinoma remains controversial. We report the outcome of BCS in BRCA mutation carriers followed at a single institution...
Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal womenGiovanni Battista Ivaldi
Department of Radiation Oncology, European Institute of Oncology, Milan, Italy
Int J Radiat Oncol Biol Phys 72:485-93. 2008..To report the acute and preliminary data on late toxicity of a pilot study of boost with electron intraoperative therapy followed by hypofractionated external beam radiotherapy (HEBRT) of the whole breast...
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancerRosalba Torrisi
Research Unit of Medical Senology, European Institute of Oncology, Milan, Italy
Clin Breast Cancer 10:483-8. 2010..Given its low cardiotoxicity, the combination of PLD and trastuzumab appears most attractive in the treatment of human epidermal factor receptor 2 (HER2)-positive breast cancer...
Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumabSilvia Dellapasqua
Medical Senology Research Unit, Department of Medicine, European Institute of Oncology, Milan, Italy
Breast 21:309-13. 2012..There is an urgent need for the identification of commonly assessable predictive factors in the treatment of patients with metastatic breast cancer...
Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activityEmilia Montagna
Department of Medicine, European Institute of Oncology, Milan, Italy
Clin Breast Cancer 12:207-14. 2012..The analysis of the results suggests that the metronomic chemotherapy combined with bevacizumab and erlotinib is effective and well tolerated...
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentationEmilia Montagna
Division of Medical Oncology, Department of Medicine, Unit Research of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast Cancer Res Treat 129:867-75. 2011..The outcome of OBC patients is comparable with that of matched patients with small sized breast cancer. High risk of relapse and death was observed in OBC patients with triple negative tumours and extensive nodal involvement...
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancerRosalba Torrisi
Research Unit of Medical Senology at the Department of Medicine, European Institute of Oncology, Milano, Italy
Breast Cancer Res Treat 126:431-41. 2011....
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvementMarco Colleoni
Division of Medical Oncology, Department of Medicine, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milan, Italy
J Clin Oncol 23:1379-89. 2005....
Breast-conserving surgery in 201 very young patients (<35 years)Oreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Breast 19:55-8. 2010..Surgical treatment of breast cancer in very young patients (<35 years) is still a matter of debate, since age is a predictive factor of local recurrence after breast conservation...
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapyMarco Colleoni
Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 116:359-69. 2009..4, 95% CI 3.5-11.6, for DFS; HR 3.6 95% CI 2.4-5.6 for OS). Response and outcome after PCT are correlated with the degree of expression of steroid hormone receptors. Studies on tailored preoperative therapies are needed...
The sentinel node biopsy under local anesthesia in breast cancer: advantages and problems, how the technique influenced the activity of a breast surgery department; update from the European Institute of Oncology with more than 1000 casesAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast 16:527-32. 2007..We are now discussing the impact of the SLNB under local anesthesia on the activity of a breast surgery department. We also present an update of our experience...
Unnecessary axillary node dissections in the sentinel lymph node eraMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy
Eur J Cancer 43:2664-8. 2007..As the clinical indications to SNB are progressively extending to encompass most breast cancer patients with non-metastatic disease who were previously excluded, great effort should be made to avoid 'unnecessary ALNDs'...
Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 proceduresMattia Intra
Division of Breast Surgery, European Institute of Oncology, University of Milan, Milan, Italy
Surgery 140:467-71. 2006
Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 casesChiara Trentin
Division of Breast Radiology, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Breast 21:635-40. 2012..To predict presence of invasive component and nodal involvement in women diagnosed preoperatively with ductal carcinoma in situ (DCIS) by vacuum-assisted breast biopsy (VABB)...
A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT)Mattia Intra
Department of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res 7:R828-32. 2005..Mastectomy is therefore recommended as the first option treatment in these women...
When sentinel lymph node is intramammaryMattia Intra
Breast Surgery Department, European Institute of Oncology, Via Ripamonti 435, Milan, MI 20141, Italy
Ann Surg Oncol 15:1304-8. 2008..Little attention has been placed to the presence of intramammary sentinel lymph nodes (intraMSLNs) on preoperative lymphoscintigraphy...
Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptorsRosalba Torrisi
Research Unit in Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast 17:654-60. 2008..Endocrine therapy administered together with new intravenous, containing regimens should be explored in the preoperative treatment of endocrine responsive breast cancer...
The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of lifeAlberto Luini
Senology Division, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 89:69-74. 2005..We previously published our preliminary experience with 115 patients; here we present an update of our experience with particular attention devoted to quality of life...
Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 yearsAliana Guerrieri-Gonzaga
Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
Oncologist 14:201-12. 2009..We analyzed risk factors and treatment outcome in a large series of women treated at one institution...
Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of OncologyViviana Galimberti
Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy
Ann Surg 253:580-4. 2011..Our aim was to evaluate the influence of margin status on outcomes with a view assessing the appropriateness of conservative surgery in this breast cancer subtype...
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancerMarco Colleoni
Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy
Eur J Cancer 46:2216-24. 2010..Tools able to predict pathological complete response (pCR) to preoperative chemotherapy might improve treatment outcome...
Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancerMattia Intra
Breast Division, University of Milan, Italy
Arch Surg 137:737-40. 2002..In our experience, IORT for limited-stage breast carcinoma is easy to perform and only briefly prolongs the duration of the surgical procedure...
Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literatureMujgan Caliskan
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 112:513-21. 2008..The objective of this study was to retrospectively analyze outcome of patients affected by Paget's breast disease and to define our institutional experience...
Invasive lobular breast cancer: subtypes and outcomeMonica Iorfida
Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 133:713-23. 2012..The outcome of ILC significantly correlated with histological and immunohistochemically defined molecular subtypes. New tailored strategies should be explored in these subgroups of patients with poor outcome...
Long-term side effects and cosmetic outcome in a pool of breast cancer patients treated with intraoperative radiotherapy with electrons as sole treatmentMaria Cristina Leonardi
Division of Radiation Oncology, European Institute of Oncology, Milan, Italy
Tumori 98:324-30. 2012..To evaluate late toxicity and cosmetic outcome after intraoperative radiotherapy using electrons (ELIOT) as sole treatment modality in early breast cancer patients...
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of OncologyMaria Cristina Leonardi
Division of Radiation Oncology, European Institute of Oncology, Milan, Italy
Int J Radiat Oncol Biol Phys 83:806-13. 2012....
Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancerAndrea Rocca
Research Unit in Medical Senology, Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Anticancer Res 29:5111-9. 2009..The prognostic role of serum levels of molecular biomarkers during the perioperative period in patients with early breast cancer is not clear...
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiationGiovanni Paganelli
Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast 16:17-26. 2007..7 GBq 90Y-biotin (100mCi). A further large clinical trial facing IART in combination with reduced external-beam radiotherapy is, in our opinion, fully justified...
Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institutionOreste Gentilini
Division of Senology, European Institute of Oncology, Milano, Italy
Ann Surg Oncol 18:2879-84. 2011..This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution...
Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancerMonica Iorfida
Unit of Research in Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast 19:128-32. 2010..Combined trastuzumab and intravenous vinorelbine yielded high clinical activity as preoperative treatment in patients (pts) with HER 2/neu positive breast cancer...
Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patientsRoberto Gennari
Department of Surgery, European Institute of Oncology, Milan, Italy
Cancer 101:1302-10. 2004..The aim of the study was to evaluate the relation between biologic features at first diagnosis of breast carcinoma and treatment choice for postmenopausal women > or = 50 years to optimize treatment in the elderly...
No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN)Gabriel Farante
Division of Senology, European Institute of Oncology, 20141 Milan, Italy
Eur J Cancer 46:476-8. 2010..Even if the SLNB is positive, AD should not be performed immediately but only in cases where an invasive component is found on definitive pathological examination of the DIN lesions...
Intraoperative radiotherapy during breast conserving surgery in patients previously treated with radiotherapy for Hodgkin's diseaseMattia Intra
Department of Breast Surgery, University of Milan, Italy
Tumori 90:13-6. 2004..Mastectomy is therefore recommended as the preferred treatment option in these women...
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgeryUmberto Veronesi
Office of the Scientific Director, Milan, Italy
Arch Surg 138:1253-6. 2003..Intraoperative RT delivered with electrons at the total isodose of 2100 rad (21 Gy) could in principle substitute the currently used radiation course of external RT after breast-conserving surgery in selected cases...
Clinical experience with axillary presentation breast cancerViviana Galimberti
Department of Senology, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 88:43-7. 2004..We present guidelines for the work-up of patients presenting with axillary disease...
Report on a case of breast sarcoma metastatic to the axillary lymph nodesJack Antonio Diaz Brito
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Tumori 92:188-90. 2006..We report a case of a 65-year-old woman affected by follicular dendritic cell sarcoma of the left breast. Six months after breast surgery she developed an axillary metastasis from the same disease...
Conservative surgery in patients with multifocal/multicentric breast cancerOreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 113:577-83. 2009..We retrospectively evaluate outcome of patients with MF/MC cancers who had breast conservation with specific attention on local control and predictive factors of recurrence...
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotinGiovanni Paganelli
European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Eur J Nucl Med Mol Imaging 37:203-11. 2010..Reduced duration EBRT (40 Gy) is given subsequently...
Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breastMattia Intra
Department of Breast Surgery, European Institute of Oncology, Milan, Italy
Arch Surg 138:309-13. 2003....
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatmentMarco Colleoni
Department of Medicine, European Institute of Oncology, Milan, Italy
Clin Cancer Res 10:6622-8. 2004..The purpose of this research was to identify factors predicting response to preoperative chemotherapy...
Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patientsViviana Galimberti
Divisions of Senology, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 9:924-8. 2002..Use of lymphoscintigraphy to visualize sentinel nodes reveals that IMNs often receive lymph from the area containing the tumor...
Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgeryMaria T Sandri
Unit of Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Ann Surg Oncol 17:1539-45. 2010..If the presence of CTCs in early breast cancer could predict an increased risk for relapse, it might be an early marker for treatment efficacy and could help in deciding treatment continuation...
Full-dose intraoperative radiotherapy with electrons in breast surgery: broadening the indicationsMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Arch Surg 140:936-9. 2005....
The nipple-sparing mastectomy: early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicatedJean Yves Petit
Plastic Surgery Division, European Institute of Oncology, Milan, Italy
Tumori 89:288-91. 2003..The nipple-sparing mastectomy is performed leaving 5 mm of glandular tissue behind the nipple areola complex to preserve its blood supply. The reconstruction is immediately performed with a prosthesis or an autologous flap...
Biomarkers for risk assessment and prevention of breast cancerMassimiliano Cazzaniga
Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Curr Cancer Drug Targets 9:482-99. 2009....
Less aggressive surgery and radiotherapy is the way forwardAlberto Costa
Division of Breast Surgery, Fondazione Salvatore Maugeri, Via Ferrata 8, 27100 Pavia, Italy
Curr Opin Oncol 16:523-8. 2004..The progressive reduction of the extension of surgery in the breast and in the axilla is now accompanied by a reduction of the radiation field. This article provides an update on conservative therapy for breast cancer...
Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic featuresS Menard
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Br J Cancer 69:1126-9. 1994..Thus, the presence of immunoreactive cells in bone marrow correlates with the expression in the primary tumour of a marker of the metastatic potential of the tumour, the 67 kDa laminin receptor...
Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational studyA Guerrieri-Gonzaga
Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
Ann Oncol 21:949-54. 2010..Since low-dose tamoxifen showed a favorable modulation of breast cancer biomarkers in phase II trials, a monoinstitutional cohort of women with DIN treated with low-dose tamoxifen or no systemic treatment was analyzed...
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspectsC De Cicco
Nuclear Medicine, Radiology, Senology and Pathology Divisions, European Institute of Oncology, Milan, Italy
Q J Nucl Med 46:145-51. 2002..4%) benign lesions and 407 (52.6%) cancers. The cancers were treated by conservative breast surgery in 99.5% of cases. CONCLUSIONS: We concluded that ROLL enables the surgeon to remove occult breast lesions easily and reliably...
Intraoperative radiation therapy for breast cancer: technical notesUmberto Veronesi
Breast Department, European Institute of Oncology, Milan, Italy
Breast J 9:106-12. 2003..Here we report the two different techniques in use in these trials...
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large seriesU Veronesi
Senology Division, Istituto Europeo di Oncologia, Milan, Italy
J Natl Cancer Inst 91:368-73. 1999....
HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17Rosalba Torrisi
Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Eur J Cancer 43:2339-44. 2007..Our results suggest that FISH testing should be considered for tumours with 50% positive stained cells and that polysomy 17 without amplification is not associated with poor prognostic features...
Urinary bladder metastases from breast carcinoma: review of the literature starting from a clinical caseGiovanna Gatti
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Tumori 91:283-6. 2005..Patients with breast cancer presenting with urinary symptoms should be examined for possible bladder metastases...
Male breast cancer: a special therapeutic problem. Anything new? (Review)Roberto Gennari
Department of Surgery, European Institute of Oncology, 20141 Milano, Italy
Int J Oncol 24:663-70. 2004....
Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology GroupStefano Zurrida
Department of Senology, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 9:156-60. 2002..We evaluated disease-free and overall survival in patients with early breast cancer treated by breast-conservation surgery without dissection of axillary lymph nodes, receiving or not receiving axillary radiotherapy (RT)...
Adenomyoepithelioma of the breast, presenting as a cancerGiovanna Gatti
Senology Division, European Oncology Institute, Milan, Italy
Tumori 90:337-9. 2004..Adenomyoepithelioma is a rare lesion that can involve the breast tissue. The diagnostic appearance of the lesion can give rise to a difficult differential diagnosis with breast carcinoma...
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkersAndrea Decensi
Division of Chemoprevention, European Institute of Oncology, and University of Milan School of Medicine, Milan, Italy
J Natl Cancer Inst 95:779-90. 2003....
Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancerNavneet Kaur
Department of Plastic and Reconstructive Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy
Ann Surg Oncol 12:539-45. 2005..The aim of this study was to evaluate the oncological safety of oncoplastic procedures by studying the status of the surgical margins of the excised tumor specimen in comparison with standard quadrantectomies...
A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancerAndrea Rocca
Unit of Research in Medical Senology, Department of Medicine, Division of Pathology, University of Milan School of Medicine, Italy
Anticancer Drugs 17:1201-9. 2006..Perioperative chemotherapy failed to show an increase in the pathological complete remission rate. A biological effect on Ki-67 expression was demonstrated...
One hundred and eleven cases of breast conservation treatment with simultaneous reconstruction at the European Institute of Oncology (Milan)Jean Yves Petit
Department of Plastic Surgery, European Institute of Oncology, Milan, Italy
Tumori 88:41-7. 2002..At the European Institute of Oncology (EIO) we use various plastic procedures to reshape the breast and to improve symmetry. The choice of these techniques depends on tumor size and location, as well as on breast volume...
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancerUmberto Veronesi
Department of Senology, European Institute of Oncology, Milan, Italy
N Engl J Med 347:1227-32. 2002..We conducted 20 years of follow-up of women enrolled in a randomized trial to compare the efficacy of radical (Halsted) mastectomy with that of breast-conserving surgery...
Systemic therapy as a first choice treatment for idiopathic granulomatous mastitisFausto Maffini
Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy
J Cutan Pathol 36:689-91. 2009....
Report on a case of pure cribriform carcinoma of the breast with internal mammary node metastasis: description of the case and review of the literatureGiovanna Gatti
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Tumori 92:241-3. 2006..Internal mammary node metastases are not frequently detected when the axillary nodes are negative...
Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five casesTommaso De Pas
New Drugs Development and Clinical Pharmacology Unit, Department of Medicine, European Institute of Oncology, Milan, Italy
Crit Rev Oncol Hematol 65:1-7. 2008..Both the analytic revision of the literature and our data suggest that localized DCS may be effectively treated by radical surgery and do not support the use of adjuvant treatments after radical excision...
Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesionsConcetta De Cicco
Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy
Cancer Biother Radiopharm 19:621-6. 2004..However, its use in nonpalpable tumors is not recommended...
Analysis of local and regional recurrences in breast cancer after conservative surgeryE Botteri
Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Ann Oncol 21:723-8. 2010..A minority of patients treated conservatively for breast cancer will develop local or regional recurrences. Our aim was to determine how their occurrence may be linked to the evolution of the disease...
